July/August 2018 JEH: Direct From CDC/Environmental Health Services
July/August 2018 Journal of Environmental Health (Volume 81, Number 1)
Editor's Note: NEHA strives to provide up-to-date and relevant information on environmental health and to build partnerships in the profession. In pursuit of these goals, we feature a column on environmental health services from the Centers for Disease Control and Prevention (CDC) in every issue of the Journal.
In these columns, authors from CDC's Water, Food, and Environmental Health Services Branch, as well as guest authors, will share insights and information about environmental health programs, trends, issues, and resources. The conclusions of these columns are those of the author(s) and do not necessarily represent the official position of CDC.
Advancing Public Health Department Legionnaires’ Disease Prevention Efforts Through the Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement
LCDR Candis Hunter, MSPH
CDR Laura Cooley, MPHTM, MD
CDR Jasen Kunz, MPH
Legionnaires’ disease (LD) is a severe respiratory illness caused by breathing in aerosolized water containing Legionella bacteria. Legionella-related outbreaks account for almost 60% of reported potable water outbreaks. The number of reported LD cases has increased 350% since 2000. The reason for this increase is unknown but is likely multifactorial and due to increased susceptible populations, opportunities for Legionella growth in the environment, or awareness with improved testing and reporting.
Based on the association of Legionella with water in built environments, implementation of effective water management programs (WMPs) has been cited as an important LD prevention measure, Health departments might not have the environmental expertise or resources, however, to provide WMP guidance. Anticipating the need for WMP expertise, the Centers for Disease Control and Prevention’s National Center for Environmental Health and National Center for Immunization and Respiratory Diseases LD team has funded state and local health agencies in 2016 through the Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement to build capacity for LD response and prevention. This month’s column explores the goals and work being done through this funding.